Name: Immunome, Inc. (IMNM) Balance Sheet
Creator: FinSpry

Immunome Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Immunome, Inc. (IMNM) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	143.35	98.68	20.32	49.23	39.77
Short-Term Investments	73.95	39.46	0.00	0.00	0.00
Cash & Short-Term Investments	217.30	138.14	20.32	49.23	39.77
Accounts Receivable	0.00	0.29	0.85	4.31	0.85
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	4.04	6.56	1.03	2.51	2.28
Total Current Assets	221.34	144.70	22.65	56.64	42.89
Non-Current Assets
Property, Plant & Equipment (Net)	14.39	3.64	0.97	0.86	1.53
Other Non-Current Assets	4.51	0.20	0.10	0.10	0.10
Total Non-Current Assets	18.90	3.84	1.40	1.29	1.63
Total Assets	240.24	148.54	24.05	57.93	44.53
Current Liabilities
Accounts Payable	14.19	3.31	2.40	3.08	1.19
Short-Term Debt	0.06	0.00	0.00	0.00	0.48
Current Portion of Long-Term Debt	0.00	0.00	0.00	0.00	0.48
Accrued Liabilities	25.12	6.98	4.62	4.31	1.27
Deferred Revenue	6.94	10.49	0.00	0.00	0.00
Other Current Liabilities	33.11	0.73	0.09	2.34	0.10
Total Current Liabilities	54.31	21.83	7.33	9.73	3.04
Non-Current Liabilities
Long-Term Debt	4.77	1.34	0.06	0.00	0.13
Other Non-Current Liabilities	0.00	1.34	0.06	0.01	0.01
Total Non-Current Liabilities	4.77	6.83	0.06	0.01	0.26
Total Liabilities	59.08	28.66	7.39	9.74	3.18
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.00
Retained Earnings	-515.77	-222.81	-116.00	-79.11	-54.39
Accumulated Other Comprehensive Income	0.06	0.02	0.00	0.00	0.00
Additional Paid-in Capital	696.87	342.66	132.65	127.29	95.74
Shares Outstanding	64.46	43.25	12.13	12.11	0.00
Total Stockholders' Equity	181.17	119.88	16.65	48.19	41.35
Total Liabilities & Equity	240.24	148.54	24.05	57.93	44.53